Yanwei Ye

468 total citations
23 papers, 315 citations indexed

About

Yanwei Ye is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Yanwei Ye has authored 23 papers receiving a total of 315 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 10 papers in Cancer Research and 5 papers in Oncology. Recurrent topics in Yanwei Ye's work include Cancer, Hypoxia, and Metabolism (6 papers), Fibroblast Growth Factor Research (5 papers) and Kruppel-like factors research (4 papers). Yanwei Ye is often cited by papers focused on Cancer, Hypoxia, and Metabolism (6 papers), Fibroblast Growth Factor Research (5 papers) and Kruppel-like factors research (4 papers). Yanwei Ye collaborates with scholars based in China and United States. Yanwei Ye's co-authors include Xiefu Zhang, Chunlin Zhao, Guojun Wang, Guang‐Hui Liu, Guojun Wang, Junmin Song, Zhen Wang, Yang Fu, Yang Sun and Yulin Li and has published in prestigious journals such as Biochemical and Biophysical Research Communications, Life Sciences and Cellular Signalling.

In The Last Decade

Yanwei Ye

23 papers receiving 308 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yanwei Ye China 10 181 93 74 45 31 23 315
He Hu China 10 165 0.9× 104 1.1× 132 1.8× 56 1.2× 55 1.8× 18 342
Ranran Shi China 11 125 0.7× 68 0.7× 71 1.0× 22 0.5× 36 1.2× 25 302
Jia Gao China 13 178 1.0× 120 1.3× 59 0.8× 37 0.8× 39 1.3× 25 407
Ailing Zhong China 13 192 1.1× 104 1.1× 124 1.7× 59 1.3× 23 0.7× 29 355
Weiying Li China 11 143 0.8× 106 1.1× 126 1.7× 97 2.2× 37 1.2× 29 363
Jiong Yang China 9 244 1.3× 132 1.4× 81 1.1× 60 1.3× 46 1.5× 14 415
Valentina Doneddu Italy 11 175 1.0× 110 1.2× 117 1.6× 66 1.5× 30 1.0× 17 336
Ieman Aljahdali United States 8 298 1.6× 88 0.9× 121 1.6× 67 1.5× 52 1.7× 8 406
Langzhu Tan United States 8 252 1.4× 53 0.6× 77 1.0× 29 0.6× 45 1.5× 9 362

Countries citing papers authored by Yanwei Ye

Since Specialization
Citations

This map shows the geographic impact of Yanwei Ye's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yanwei Ye with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yanwei Ye more than expected).

Fields of papers citing papers by Yanwei Ye

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yanwei Ye. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yanwei Ye. The network helps show where Yanwei Ye may publish in the future.

Co-authorship network of co-authors of Yanwei Ye

This figure shows the co-authorship network connecting the top 25 collaborators of Yanwei Ye. A scholar is included among the top collaborators of Yanwei Ye based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yanwei Ye. Yanwei Ye is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Liu, Xinyu, et al.. (2025). PRMT5-FOXM1 axis activates β-catenin/IL8 signaling to drive angiogenesis of gastric cancer. Cellular Signalling. 134. 111925–111925. 2 indexed citations
2.
Liu, Dongdong, et al.. (2024). The expression and clinical significance of serine hydroxymethyltransferase2 in gastric cancer. PeerJ. 12. e16594–e16594. 3 indexed citations
3.
Ye, Yanwei, Jie Li, Chao Han, et al.. (2020). Role of fibroblast growth factor 4 in the growth and metastasis of colorectal cancer. International Journal of Oncology. 56(6). 1565–1573. 3 indexed citations
4.
Ye, Yanwei, et al.. (2020). FGFR4 Gly388Arg Polymorphism Affects the Progression of Gastric Cancer by Activating STAT3 Pathway to Induce Epithelial to Mesenchymal Transition. Cancer Research and Treatment. 52(4). 1162–1177. 5 indexed citations
5.
Wang, Guojun, Guanghui Liu, Yanwei Ye, Yang Fu, & Xiefu Zhang. (2019). Bufothionine exerts anti-cancer activities in gastric cancer through Pim3. Life Sciences. 232. 116615–116615. 20 indexed citations
6.
Sun, Yang, et al.. (2019). High expression of fibronectin 1 indicates poor prognosis in gastric cancer. Oncology Letters. 19(1). 93–102. 54 indexed citations
7.
Li, Jingjing, Jie Li, Min Wang, et al.. (2017). Combination of FGFR4 inhibitor Blu9931 and 5-fluorouracil effects on the biological characteristics of colorectal cancer cells. International Journal of Oncology. 51(5). 1611–1620. 9 indexed citations
8.
Wang, Guojun, Yang Fu, Guang‐Hui Liu, Yanwei Ye, & Xiefu Zhang. (2016). miR-218 Inhibits Proliferation, Migration, and EMT of Gastric Cancer Cells by Targeting WASF3. Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics. 25(3). 355–364. 31 indexed citations
9.
Liu, Tao, Xiefu Zhang, Yaqing Si, et al.. (2015). Intensive Versus Conventional Glycemic Control in Patients with Diabetes During Enteral Nutrition After Gastrectomy. Journal of Gastrointestinal Surgery. 19(8). 1553–1558. 24 indexed citations
10.
Wang, Guojun, et al.. (2015). The role of microRNA-1274a in the tumorigenesis of gastric cancer: Accelerating cancer cell proliferation and migration via directly targeting FOXO4. Biochemical and Biophysical Research Communications. 459(4). 629–635. 28 indexed citations
11.
Li, Jingjing, Yanwei Ye, Min Wang, et al.. (2015). The over-expression of FGFR4 could influence the features of gastric cancer cells and inhibit the efficacy of PD173074 and 5-fluorouracil towards gastric cancer. Tumor Biology. 37(5). 6881–6891. 11 indexed citations
12.
Zhang, Xiefu, Tao Liu, Yanwei Ye, et al.. (2015). Hyperthermia combined with 5-fluorouracil promoted apoptosis and enhanced thermotolerance in human gastric cancer cell line SGC-7901. OncoTargets and Therapy. 8. 1265–1265. 9 indexed citations
13.
Liu, Tao, Yanwei Ye, Xiefu Zhang, et al.. (2015). Downregulation of non-muscle myosin IIA expression inhibits migration and invasion of gastric cancer cells via the c-Jun N-terminal kinase signaling pathway. Molecular Medicine Reports. 13(2). 1639–1644. 16 indexed citations
14.
Ye, Yanwei, Jingjing Li, Min Wang, et al.. (2015). Silencing of FGFR4 could influence the biological features of gastric cancer cells and its therapeutic value in gastric cancer. Tumor Biology. 37(3). 3185–3195. 7 indexed citations
15.
Wang, Guojun, Yanwei Ye, Xiefu Zhang, Hongxiang Liu, & Junmin Song. (2015). A single-arm clinical study of continuous usage of bevacizumab as second-line chemotherapy for Chinese patients with metastatic colorectal cancer. Medical Oncology. 32(5). 163–163. 3 indexed citations
16.
Ye, Yanwei, Min Wang, Jing Li, et al.. (2015). Hypoxia-inducible factor-1α G polymorphism and the risk of cancer: a meta-analysis.. PubMed. 100(6). e257–65. 2 indexed citations
17.
Wang, Guojun, Yanwei Ye, Xiefu Zhang, & Junmin Song. (2014). Bradykinin stimulates IL-6 production and cell invasion in colorectal cancer cells. Oncology Reports. 32(4). 1709–1714. 39 indexed citations
18.
Li, Jingjing, Zu‐Jiang Yu, Duolu Li, et al.. (2014). Hyperammonia induces specific liver injury through an intrinsic Ca2+-independent apoptosis pathway. BMC Gastroenterology. 14(1). 151–151. 15 indexed citations
19.
Ye, Yanwei, Min Wang, Shuang Hu, et al.. (2014). Hypoxia-Inducible Factor-1α C1772T Polymorphism and Cancer Risk: A Meta-Analysis Including 18,334 Subjects. Cancer Investigation. 32(4). 126–135. 7 indexed citations
20.
Ye, Yanwei, Min Wang, Jingjing Li, et al.. (2014). Hypoxia-Inducible Factor-1α G Polymorphism and the Risk of Cancer: A Meta-Analysis. Tumori Journal. 100(6). e257–e265. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026